Company / Book Value per Share
Lineage Cell Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.202
FY2025
5-year range
$0.202 / $0.602
FY2021-FY2025
Trend
-54.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from $0.202 in FY2025 to $1.582 in FY2017.
Based on SEC 10-K filings.
$0.202 in FY2025 with a 5-year CAGR of -20.6%.
Declined from $0.373 to $0.202 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -22.4%
- 5-Year CAGR
- -20.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -20.6%, indicating a declining trend.
- In FY2025, book value per share decreased 54.9% year-over-year.
- Peak book value per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.202 | -54.9% |
| FY2024 | $0.448 | +20.1% |
| FY2023 | $0.373 | -13.8% |
| FY2022 | $0.433 | -28.2% |
| FY2021 | $0.602 | -6.2% |
| FY2020 | $0.642 | -13.0% |
| FY2019 | $0.738 | -0.2% |
| FY2018 | $0.74 | -53.3% |
| FY2017 | $1.582 | +21.3% |
| FY2016 | $1.304 | +279.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026